BALAXI PHARMACEUTICALS balance sheet

·UnclassifiedChart ›

As of Mar 2026

Total assets: ₹337cr+8.6% on Mar 2025
Shareholders' equity: ₹249cr+7.5% on Mar 2025
Total debt: ₹55.8cr+8.1% on Mar 2025
Cash and investments: ₹14.6cr−63.1% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	49.0	14.2	14.8	16.2
	—	22.1	2.3	2.8
	32.7	26.7	26.1	25.2
	3.9	4.5	5.0	1.9
	3.9	4.5	5.0	1.9
	85.6	67.6	48.2	46.2
	83.5	78.5	82.2	105
	136	111	55.7	53.4
	14.6	39.4	62.3	28.2
	0.0	0.0	0.0	0.0
	0.4	3.1	1.9	1.6
	—	11.0	0.0	5.2
	151	164	120	88.5
	14.6	—	8.1	—
	251	243	210	194
	337	310	258	240
Equity
	11.0	11.0	10.9	10.2
	238	221	190	173
	249	232	201	183
	249	232	201	183
Liabilities
	22.4	21.2	0.0	0.9
	1.9	—	0.0	0.0
	24.2	21.2	0.0	0.9
	0.2	0.1	0.0	0.0
	1.3	0.9	1.0	1.1
	—	1.8	1.7	1.7
	25.8	24.1	2.8	3.7
	33.4	30.4	17.7	10.8
	21.2	16.2	29.0	36.5
	0.2	0.0	0.0	0.8
	54.6	46.6	46.7	48.1
	0.0	0.0	2.9	0.0
	2.1	3.4	0.0	5.1
	5.4	4.6	4.6	0.0
	62.2	54.5	54.2	53.1
	88.0	78.6	57.0	56.8
	337	310	258	240
Assets — additional as-filed lines
	2.3	—	0.0	—
Trade payables — MSME split
	21.2	7.6	—	—
	0.0	8.6	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BALAXI₹19.71

BALAXI PHARMACEUTICALS LIMITED

· Unclassified

₹ CrorePeersPAR STEELCITY LATTEYS CROWN HECPROJECT HINDCON AIROLAM GROBTEAMcap ₹109 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	16.2	14.8	14.2	49.0	49.0
+ Capital Work-in-Progress	2.8	2.3	22.1	—	—
+ Goodwill	25.2	26.1	26.7	32.7	32.7
+ Other Non-current Financial Assets	1.9	5.0	4.5	3.9	3.9
Non-current Financial Assets	1.9	5.0	4.5	3.9	3.9
Total Non-current Assets	46.2	48.2	67.6	85.6	85.6
Current Assets
+ Inventories	105.0	82.2	78.5	83.5	83.5
+ Trade Receivables	53.4	55.7	110.8	136.1	136.1
+ Cash & Cash Equivalents	28.2	62.3	39.4	14.6	14.6
+ Other Bank Balances	0.0	0.0	0.0	0.0	0.0
+ Short-term Loans	1.6	1.9	3.1	0.4	0.4
+ Other Current Financial Assets	5.2	0.0	11.0	—	—
Current Financial Assets	88.5	119.9	164.3	151.1	151.1
+ Other Current Assets	—	8.1	—	14.6	14.6
Total Current Assets	193.5	210.2	242.8	251.4	251.4
Total Assets	239.7	258.3	310.3	337.0	337.0
Equity
+ Equity Share Capital	10.2	10.9	11.0	11.0	11.0
+ Other Equity / Reserves	172.7	190.5	220.7	238.0	238.0
Equity — Owners of Parent	182.9	201.4	231.7	249.1	249.1
Total Equity	182.9	201.4	231.7	249.1	249.1
Liabilities
+ Borrowings — Non-current	0.9	0.0	21.2	22.4	22.4
+ Other Non-current Financial Liab	0.0	0.0	—	1.9	1.9
Non-current Financial Liabilities	0.9	0.0	21.2	24.2	24.2
+ Provisions — Non-current	0.0	0.0	0.1	0.2	0.2
+ Deferred Tax Liabilities	1.1	1.0	0.9	1.3	1.3
+ Other Non-current Liabilities	1.7	1.7	1.8	—	—
Non-current Liabilities	3.7	2.8	24.1	25.8	25.8
+ Borrowings — Current	10.8	17.7	30.4	33.4	33.4
+ Trade Payables	36.5	29.0	16.2	21.2	21.2
+ Other Current Financial Liab	0.8	0.0	0.0	0.2	0.2
Current Financial Liabilities	48.1	46.7	46.6	54.6	54.6
+ Provisions — Current	0.0	2.9	0.0	0.0	0.0
+ Current Tax Liabilities	5.1	0.0	3.4	2.1	2.1
+ Other Current Liabilities	0.0	4.6	4.6	5.4	5.4
Current Liabilities	53.1	54.2	54.5	62.2	62.2
Total Liabilities	56.8	57.0	78.6	88.0	88.0
Total Equity & Liabilities	239.7	258.3	310.3	337.0	337.0
Assets — additional as-filed lines
+ Current Tax Assets	—	0.0	—	2.3	2.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	7.6	21.2	21.2
+ Dues to Other Creditors — Current	—	—	8.6	0.0	0.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.